secwatch.observer — SEC 8-K summary
======================================

Issuer:     PRECISION BIOSCIENCES INC (DTIL)
CIK:        0001357874
Form:       8-K
Filed at:   2023-02-24T23:59:59+00:00
Accession:  0000950170-23-004240
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Precision BioSciences promotes Neil Leatherbury to SVP CMC; co-founder Derek Jantz moves to advisory role
--------------------------------------------------------------------------------

- Neil Leatherbury promoted to SVP, Head of CMC, reporting to CEO Michael Amoroso.
- Co-founder Derek Jantz steps down as CSO, becomes Co-Founder and Chief Science Advisor.
- Co-founder Jeff Smith continues as Chief Research Officer, now leads joint steering committees with Lilly and Novartis.
- CMC promotion follows FDA Type C feedback on azer-cel manufacturing processes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357874/000095017023004240/0000950170-23-004240-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357874/000095017023004240/dtil-20230222.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-004240

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer